{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:53:36Z","timestamp":1781643216729,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cuiying Science and Technology Innovation Program Project of the Second Hospital of Lanzhou University","award":["CY2022-MS-A18"],"award-info":[{"award-number":["CY2022-MS-A18"]}]},{"name":"the Project of the Education Department of Gansu Province","award":["2021jyjbgs-02"],"award-info":[{"award-number":["2021jyjbgs-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer is an aggressive malignancy with poor prognosis and frequent resistance to standard anticancer therapies, highlighting the need for treatments that more effectively induce tumor cell death. Here, we aimed to identify a drug candidate that triggers cell death and to uncover its molecular mechanism in pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed high-throughput screening using a library of 2,051 FDA-approved compounds in pancreatic cancer cells and used cell viability assays to identify agents that induce cell death. The antitumor effects of the lead compound were characterized by transmission electron microscopy, mCherry-EGFP-LC3B, lipid peroxidation and mitochondrial function assays, and an orthotopic LSL-Kras\n                      <jats:sup>G12D\/+<\/jats:sup>\n                      , LSL-Trp53\n                      <jats:sup>R172H\/+<\/jats:sup>\n                      , Pdx1-Cre (KPC) mouse model. Single-cell RNA sequencing, surface plasmon resonance (SPR), co-immunoprecipitation, and western blotting were used to elucidate the underlying mechanism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High-throughput screening identified the antiarrhythmic agent dronedarone as a compound that significantly inhibited pancreatic cancer cell growth and can exert effective antitumor effects in vivo. Single-cell RNA sequencing and pharmacologic rescue experiments indicated that ferroptosis is a major form of dronedarone-induced regulated cell death in pancreatic cancer cells. Mechanistically, dronedarone directly bound to glutathione peroxidase 4 (GPX4), inhibited its enzymatic activity, and promoted p62-mediated autophagic degradation of GPX4, leading to mitochondrial lipid peroxidation and GPX4-dependent ferroptosis. Moreover, the ferroptosis inhibitor ferrostatin-1 attenuated dronedarone-induced lipid peroxidation, preserved GPX4 expression, and partially reversed its antitumor effects in the orthotopic KPC mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dronedarone serves as an unrecognized promoter of ferroptosis in pancreatic cancer by targeting p62-mediated autophagic degradation and functional inactivation of GPX4, providing a mechanistic and translational rationale for exploiting ferroptosis in pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03687-6","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:07:10Z","timestamp":1773475630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing dronedarone induces ferroptosis through GPX4 inactivation and degradation in pancreatic cancer"],"prefix":"10.1186","volume":"45","author":[{"given":"Yanmei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"publisher","first-page":"216031","DOI":"10.1016\/j.canlet.2022.216031","volume":"554","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Zhang W, Zhang Z, Sha G, Wang D, Tang D. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. Cancer Lett. 2023;554:216031.","journal-title":"Cancer Lett"},{"issue":"2","key":"3687_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1152\/physrev.00044.2023","volume":"105","author":"J Sastre","year":"2025","unstructured":"Sastre J, P\u00e9rez S, Sabater L, Rius-P\u00e9rez S. Redox signaling in the pancreas in health and disease. Physiol Rev. 2025;105(2):593\u2013650.","journal-title":"Physiol Rev"},{"issue":"1","key":"3687_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Wang H, Yang X, Wu Q, An P, Jin X, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020;5(1):138.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3687_CR4","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.cmet.2023.06.014","volume":"35","author":"X Yang","year":"2023","unstructured":"Yang X, Wang Z, Zandkarimi F, Liu Y, Duan S, Li Z, et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metab. 2023;35(8):1474\u2013e908.","journal-title":"Cell Metab"},{"issue":"7","key":"3687_CR5","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","volume":"81","author":"KV Floros","year":"2021","unstructured":"Floros KV, Cai J, Jacob S, Kurupi R, Fairchild CK, Shende M, et al. MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-\/Glutathione Axis. Cancer Res. 2021;81(7):1896\u2013908.","journal-title":"Cancer Res"},{"issue":"7860","key":"3687_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"},{"issue":"1","key":"3687_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):55.","journal-title":"Signal Transduct Target Ther"},{"issue":"1\u20132","key":"3687_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"issue":"8","key":"3687_CR9","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1158\/2159-8290.CD-23-1220","volume":"14","author":"G Lei","year":"2024","unstructured":"Lei G, Mao C, Horbath AD, Yan Y, Cai S, Yao J, et al. BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer Discov. 2024;14(8):1476\u201395.","journal-title":"Cancer Discov"},{"issue":"1","key":"3687_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41392-025-02216-9","volume":"10","author":"X Wang","year":"2025","unstructured":"Wang X, Chen T, Chen S, Zhang J, Cai L, Liu C, et al. STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation. Signal Transduct Target Ther. 2025;10(1):136.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3687_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ygyno.2018.09.019","volume":"151","author":"A Belur Nagaraj","year":"2018","unstructured":"Belur Nagaraj A, Joseph P, Kovalenko O, Wang Q, Xu R, DiFeo A. Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Gynecol Oncol. 2018;151(3):525\u201332.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3687_CR12","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1038\/s41598-018-34348-0","volume":"8","author":"MJ Elliott","year":"2018","unstructured":"Elliott MJ, Jerzak KJ, Cockburn JG, Safikhani Z, Gwynne WD, Hassell JA, et al. The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THR\u03b11) Antagonism. Sci Rep. 2018;8(1):16562.","journal-title":"Sci Rep"},{"key":"3687_CR13","doi-asserted-by":"publisher","first-page":"102136","DOI":"10.1016\/j.tranon.2024.102136","volume":"50","author":"X Lu","year":"2024","unstructured":"Lu X, Zhang W, Yang X, Yan X, Hussain Z, Wu Q, et al. Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC. Transl Oncol. 2024;50:102136.","journal-title":"Transl Oncol"},{"issue":"7","key":"3687_CR14","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","volume":"164","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ma Y, Wang T, Zhou H, Wang K, Shi W, et al. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress. Gastroenterology. 2023;164(7):1232\u201347.","journal-title":"Gastroenterology"},{"issue":"7924","key":"3687_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608(7924):778\u201383.","journal-title":"Nature"},{"issue":"8","key":"3687_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3687_CR17","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, et al. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916.","journal-title":"Drug Resist Updat"},{"issue":"7","key":"3687_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.tcm.2016.03.014","volume":"26","author":"M Vamos","year":"2016","unstructured":"Vamos M, Hohnloser SH. Amiodarone and dronedarone: An update. Trends Cardiovasc Med. 2016;26(7):597\u2013602.","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"3687_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/europace\/euab262","volume":"24","author":"A Khachatryan","year":"2022","unstructured":"Khachatryan A, Merino JL, de Abajo FJ, Botto GL, Kirchhof P, Breithardt G, et al. International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF). Europace. 2022;24(6):899\u2013909.","journal-title":"Europace"},{"issue":"3","key":"3687_CR20","doi-asserted-by":"publisher","first-page":"e020506","DOI":"10.1161\/JAHA.120.020506","volume":"11","author":"JM Wharton","year":"2022","unstructured":"Wharton JM, Piccini JP, Koren A, Huse S, Ronk CJ. Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation. J Am Heart Assoc. 2022;11(3):e020506.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3687_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s11684-024-1062-x","volume":"18","author":"B Li","year":"2024","unstructured":"Li B, Zhang J, Yu Y, Li Y, Chen Y, Zhao X, et al. Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4\/CDK6-RB1 axis in vitro and in vivo. Front Med. 2024;18(5):896\u2013910.","journal-title":"Front Med"},{"key":"3687_CR22","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.1016\/j.drup.2024.101057","volume":"73","author":"J Liang","year":"2024","unstructured":"Liang J, Bi G, Huang Y, Zhao G, Sui Q, Zhang H, et al. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. Drug Resist Updat. 2024;73:101057.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"3687_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2023.10.011","volume":"31","author":"J Rodencal","year":"2024","unstructured":"Rodencal J, Kim N, He A, Li VL, Lange M, He J, et al. Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest. Cell Chem Biol. 2024;31(2):234\u2013. \u2013\u200948.e13.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"3687_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10238-025-01933-3","volume":"26","author":"J Lin","year":"2025","unstructured":"Lin J, Chen F, Tang H, Cai X, Huang M, Liang R, et al. CDC26 facilitates ferroptosis through SLC7A11 degradation and cell cycle arrest. Clin Exp Med. 2025;26(1):11.","journal-title":"Clin Exp Med"},{"issue":"1","key":"3687_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41467-023-44412-7","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, Horbath A, Kondiparthi L, Meena JK, Lei G, Dasgupta S, et al. Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nat Commun. 2024;15(1):79.","journal-title":"Nat Commun"},{"key":"3687_CR26","doi-asserted-by":"crossref","unstructured":"Chuong MD, Ashman J, Jethwa K, Kharofa J, Koay E, Ludmir E et al. Moving from the background towards the spotlight: A critical review of radiation therapy for locally advanced pancreas cancer. Int J Radiat Oncol Biol Phys. 2025;122(2):294-312.","DOI":"10.1016\/j.ijrobp.2025.02.022"},{"key":"3687_CR27","doi-asserted-by":"crossref","unstructured":"Orlandi E, Vecchia S, Anselmi E, Toscani I, Guasconi M, Perrone G et al. Neoadjuvant Treatment in Localized Pancreatic Cancer of the Elderly: A Systematic Review of the Current Literature. Cancers (Basel). 2025;17(5):747.","DOI":"10.3390\/cancers17050747"},{"key":"3687_CR28","doi-asserted-by":"publisher","first-page":"217350","DOI":"10.1016\/j.canlet.2024.217350","volume":"610","author":"B Yu","year":"2025","unstructured":"Yu B, Shao S, Ma W. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Cancer Lett. 2025;610:217350.","journal-title":"Cancer Lett"},{"issue":"15","key":"3687_CR29","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.7150\/ijbs.99859","volume":"20","author":"SC Tsai","year":"2024","unstructured":"Tsai SC, Chang PC, Lin YT, Huang PT, Chen JY, Lin CS, et al. Repurposing of the Antipsychotic Trifluoperazine Induces SLC7A11\/GPX4- Mediated Ferroptosis of Oral Cancer via the ROS\/Autophagy Pathway. Int J Biol Sci. 2024;20(15):6090\u2013113.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"3687_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41419-024-07237-w","volume":"15","author":"Y Hirata","year":"2024","unstructured":"Hirata Y, Yamada Y, Taguchi S, Kojima R, Masumoto H, Kimura S, et al. Conjugated fatty acids drive ferroptosis through chaperone-mediated autophagic degradation of GPX4 by targeting mitochondria. Cell Death Dis. 2024;15(12):884.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3687_CR31","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136(12):4551\u20136.","journal-title":"J Am Chem Soc"},{"key":"3687_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-biochem-061516-044859","volume":"86","author":"A Varshavsky","year":"2017","unstructured":"Varshavsky A. The Ubiquitin System, Autophagy, and Regulated Protein Degradation. Annu Rev Biochem. 2017;86:123\u20138.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"3687_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41422-024-01022-2","volume":"35","author":"Q Xu","year":"2025","unstructured":"Xu Q, Wang H, Yang R, Tao Y, Wang Z, Zhang S, et al. \u03b1-Synuclein amyloid fibril directly binds to LC3B and suppresses SQSTM1\/p62-mediated selective autophagy. Cell Res. 2025;35(1):72\u20135.","journal-title":"Cell Res"},{"issue":"11","key":"3687_CR34","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1080\/15548627.2021.1872241","volume":"17","author":"J Li","year":"2021","unstructured":"Li J, Liu J, Xu Y, Wu R, Chen X, Song X, et al. Tumor heterogeneity in autophagy-dependent ferroptosis. Autophagy. 2021;17(11):3361\u201374.","journal-title":"Autophagy"},{"issue":"11","key":"3687_CR35","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41418-023-01230-0","volume":"30","author":"P Yang","year":"2023","unstructured":"Yang P, Li J, Zhang T, Ren Y, Zhang Q, Liu R, et al. Ionizing radiation-induced mitophagy promotes ferroptosis by increasing intracellular free fatty acids. Cell Death Differ. 2023;30(11):2432\u201345.","journal-title":"Cell Death Differ"},{"key":"3687_CR36","doi-asserted-by":"publisher","first-page":"108279","DOI":"10.1016\/j.bioorg.2025.108279","volume":"157","author":"MW Iqbal","year":"2025","unstructured":"Iqbal MW, Haider SZ, Nawaz MZ, Irfan M, Al-Ghanim KA, Sun X, et al. Molecular simulations guided drugs repurposing to inhibit human GPx1 enzyme for cancer therapy. Bioorg Chem. 2025;157:108279.","journal-title":"Bioorg Chem"},{"issue":"8","key":"3687_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrd.2018.46","volume":"17","author":"J Rautio","year":"2018","unstructured":"Rautio J, Meanwell NA, Di L, Hageman MJ. The expanding role of prodrugs in contemporary drug design and development. Nat Rev Drug Discov. 2018;17(8):559\u201387.","journal-title":"Nat Rev Drug Discov"},{"key":"3687_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.actbio.2021.04.034","volume":"128","author":"Y Sun","year":"2021","unstructured":"Sun Y, Yang J, Yang T, Li Y, Zhu R, Hou Y, et al. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation. Acta Biomater. 2021;128:447\u201361.","journal-title":"Acta Biomater"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03687-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:05:49Z","timestamp":1781640349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03687-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03687-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Experimentation Ethics Committee of Lanzhou University Second Hospital (No. D2024-568).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}